The placebo effect in allergen‐specific immunotherapy trials-Reference-Cited by-同舟云学术

The placebo effect in allergen‐specific immunotherapy trials

Published:2013-01 Issue:1 Volume:3 Page:42
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical and Translational Allergy

Author:

Narkus Annemie¹,Lehnigk Ulrike¹,Haefner Dietrich¹,Klinger Regine²,Pfaar Oliver³,Worm Margitta⁴

Affiliation:

1. Medical DepartmentAllergopharma GmbH & Co KGReinbekGermany

2. Department of Clinical PsychologyBehaviour TherapyUniversity of HamburgHamburgGermany

3. Department of OtorhinolaryngologyHead and Neck SurgeryUniversity Hospital MannheimMannheimGermany

4. Allergy‐Center‐CharitéDepartment of Dermatology and AllergyCharité‐Campus MitteUniversitätsmedizinBerlinGermany

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/2045-7022-3-42

Reference44 articles.

1. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables;Guyatt G;J Clin Epidemiol,2011

2. ICH Topic E 10. Choice of Control Group in Clincal Trials. Note for guidance on choice of control group in clinical trials;European Medicines Agency;CPMP/ICH/364/96,2001

3. Biological, clinical, and ethical advances of placebo effects;Finniss DG;Lancet,2010

4. European Medicines Agency: EMEA/CPMP Position Statement on the Use of Placebo in Clinical Trials with Regard to the Revised Declaration of Helsinky.London 28 June2001.EMEA/17424/01

5. Guidance for Industry. E 10 choice of control group and related issues in clinical trials;U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation (CDER). Center for Biologics Evaluation and Research (CBER);ICH,2001

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis;Allergy, Asthma & Clinical Immunology;2023-03-11

2. Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial;Journal of Allergy and Clinical Immunology;2023-01

3. Allergen-specific immunotherapy and evidence: A European regulatory perspective;Allergologie select;2023-01-01

4. Phytomedicine ELOM ‐080 in Acute Viral Rhinosinusitis: A Randomized, Placebo‐Controlled, Blinded Clinical Trial;The Laryngoscope;2022-10-12

5. Sublingual immunotherapy may be effective in reducing house dust mite allergies in children with atopic dermatitis;Acta Paediatrica;2022-07-29